|Title:||The possibility of administration of glutamate receptors antagonists in the treatment of parkinson's disease|
|Authors:||Avdeeva, N. V.|
Nikitina, V. A.
Kochkarova, I. S.
Litvinova, A. S.
diseases of the central nervous system
metabotropic glutamate receptors
|Citation:||The possibility of administration of glutamate receptors antagonists in the treatment of parkinson's disease / N. V. Avdeeva [et al.] // Research result: pharmacology and clinical pharmacology. - 2016. - Vol.2, №3.- P. 86-94. - DOI: 10.18413/2500-235X -2016-2-3-86-94. - Refer.: p. 94.|
|Abstract:||Parkinson's disease is the slow-progressing chronic neurodegenerative disease. Modern medicine has not yet found methods of curing disease, however, the existing methods of conservative and surgical treatment significantly improve the patient’s quality of life and slow the progression of the disease|
|Appears in Collections:||Research Result. Pharmacology and Clinical Pharmacology|
|Avdeeva_ The_possibility_16.pdf||921.38 kB||Adobe PDF||View/Open|
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.